Canadian Launch of Fraxel Re:pair Laser
Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments, today announced its Canadian launch of the Fraxel re:pair laser system with the recent Health Canada Clearance. The Canadian debut of the Fraxel re:pair system occurred at the recent Controversies and Conversations in Laser Cosmetic Surgery symposium in Whistler, B.C., Canada.
The Fraxel re:pair system is now available for purchase by dermatologists, plastic surgeons and cosmetic physicians in Canada. In December 2007, the Fraxel re:pair system received the industry’s first FDA 510(K) clearance for a fractional ablative laser system for treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions and vascular dyschromia.
The industry’s first minimally invasive, ablative fractional laser system, the Fraxel re:pair laser delivers a full spectrum of aesthetic treatment from mild to aggressive. It is the only ablative resurfacing device capable of being operated by a single clinician because of its built-in smoke evacuation system, and capable of treating at depths from 110 micrometers (um) to 1.6 mm into the dermis.
“Ablative fractional skin resurfacing with the Fraxel re:pair laser is a major breakthrough for my patients who desire significant tissue tightening, wrinkle reduction, and improvement in skin quality, both on and off the face,” said William McGillivray, MD, a director of Pacific Dermaesthetics in Vancouver, B.C.
Mark Lupin, MD, FRCPC, director of Cosmedica in Victoria, B.C., added, “The Fraxel re:pair system addresses the full range of photodamage - wrinkles, lines, pigment, and vascular irregularities, all in a single treatment.”
The Fraxel re:pair laser system, the result of more than three years of clinical follow-up, represents a new category in skin rejuvenation: Ablative Fractional Resurfacing (AFR(TM)) treatment. The Fraxel re:pair laser delivers treatment for superficial photodamage, including pigmentation, fine lines, texture and vascular dyschromia, and has the flexibility to provide treatment for more severe rhytides and furrows by stimulating new collagen and elastin production deep into the dermis. Treatment is delivered with the safety and
proven efficacy of a Fraxel brand treatment.
“We are pleased to announce that the Fraxel re:pair system is now available to physicians and their patients in Canada,” said Len DeBenedictis, Chief Technology Officer of Reliant Technologies. “The latest Fraxel laser system offers consumers a one-time treatment that provides dramatic results without the side effects and downtime associated with a fully-ablative or surgical procedure.”
Recently, it was announced that Reliant has agreed to join forces with Thermage, Inc. (Nasdaq: THRM) in a merger expected to close in the fourth quarter 2008.
See Also:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment